Form 4 for PMVP PMV Pharmaceuticals, Inc.
Accepted 2023-08-08 00:00:00 ET · period of report 2023-08-07 · accession 0001209191-23-045010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-08 | 2023-08-07 | PMVP | Mack David Henry | Pres, CEO, Dir | M - OptEx | $0.53 | +85.5K | 165.5K | +107% | +$45.3K |
| D | 2023-08-08 | 2023-08-07 | PMVP | Mack David Henry | Pres, CEO, Dir | M - OptEx | $0.00 | -85.5K | 307.9K | -22% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-07 | M | A | 85,500 | $0.53 | 165,470 | D | — | — | |
| 2 | Derivative | Employee Stock Option (right to buy) | 2023-08-07 | M | D | 85,500 | $0.00 | 307,866 | D | $0.53 · — to 2025-05-11 | 85,500 Common Stock | (F4) The shares subject to the option are fully vested and immediately exercisable. |